Ainoa Ugarte

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Daniel K. Nomah, Juliana Reyes‐Urueña, Yesika Díaz et al. · The Lancet HIV · 2021 · 110 citations · Full text

Public Health, Health Sciences, Infectious Diseases +17

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

Juan Ambrosioni, Jhon Rojas Liévano, Leire Berrocal et al. · Journal of Antimicrobial Chemotherapy · 2021 · 69 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19

Carolina García‐Vidal, Rodrigo Alonso, Ana M. Camon et al. · Journal of Antimicrobial Chemotherapy · 2021 · 51 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

High rates of long‐term progression in HIV‐1‐positive elite controllers

María Borrell, Irene Fernández, Flor Etcheverrry et al. · Journal of the International AIDS Society · 2021 · 27 citations · Full text

Life Sciences, Immunology, Infectious Diseases +12

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

Verónica Rico, Mariana Fernández, Juan Carlos Hurtado et al. · Infection · 2022 · 21 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +10